<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND/AIMS: Hepatic glucuronidating activity, essential for efficient biliary excretion of <z:chebi fb="0" ids="16990">bilirubin</z:chebi>, is reduced to about 30 percent of <z:mpath ids='MPATH_458'>normal</z:mpath> in patients with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Patients with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> have an additional TA insertion in the A(TA)<z:chebi fb="2" ids="32497">TAA</z:chebi> of <z:chebi fb="15" ids="17659">UDP</z:chebi>-glucuronosyltransferase 1 (UGT-1A1) promoter gene </plain></SENT>
<SENT sid="2" pm="."><plain>This results in reduced frequency and accuracy of transcription initiation and enzyme activity </plain></SENT>
<SENT sid="3" pm="."><plain>The frequency and location of the mutation vary according to races </plain></SENT>
<SENT sid="4" pm="."><plain>This study was done to determine the UGT-1A1 promoter gene mutation in Korean cases of <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>METHODS: Promoter regions of the gene for <z:chebi fb="0" ids="16990">bilirubin</z:chebi> UGT-1A1 in twelve patients with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> and twenty healthy subjects (controls) were sequenced </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: 1) Among twelve <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> five patients were homozygous for A(TA)6/6TAA, two were homozygous for A(TA)7/7TAA, and the other five were heterozygous for A(TA)6/7TAA </plain></SENT>
<SENT sid="7" pm="."><plain>The prevalence of A(TA)<z:chebi fb="2" ids="32497">TAA</z:chebi> mutation was 58.3 percent </plain></SENT>
<SENT sid="8" pm="."><plain>2) Among twenty healthy subjects seventeen were homozygous for A(TA)6/6TAA, one was homozygous for A(TA)7/7TAA, and two were heterozygous for A(TA)6/7TAA </plain></SENT>
<SENT sid="9" pm="."><plain>The prevalence of A(TA)<z:chebi fb="2" ids="32497">TAA</z:chebi> mutation was 15 percent </plain></SENT>
<SENT sid="10" pm="."><plain>3) The prevalence of A(TA)<z:chebi fb="2" ids="32497">TAA</z:chebi> mutation in <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> patients was significantly higher than in the controls (p=0.018) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: Although the prevalence of A(TA)<z:chebi fb="2" ids="32497">TAA</z:chebi> mutation in Korean patients with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> is significantly higher than in the controls, the mutations of the promoter region of UGT-1A1 gene appear not to be the main or sole cause in <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> in Korea since the prevalence of A(TA)<z:chebi fb="2" ids="32497">TAA</z:chebi> mutation is not so high </plain></SENT>
<SENT sid="12" pm="."><plain>Further studies to determine the relationship between other UGT-1A1 gene mutation and <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> in Korea are needed </plain></SENT>
</text></document>